Bioimpact Capital LLC - Q42025 Holdings

Bioimpact Capital LLC holds 38 stocks with a total portfolio value of $ 873.95M as of Q42025. In Q42025, Bioimpact Capital LLC added 15 new positions, increased stakes in 6 stocks, reduced 16 holdings, and fully exited 17 positions. The largest holding is Cullinan Therapeutics, Inc. (CGEM), representing 9.06% of the total portfolio.